Neuroprotection Impact of Cyclosporin A in Cerebral Infarction
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to determine whether a single injection of CsA after
intravenous thrombolysis can significantly decreased the volume of cerebral infarction at day
30 ± 15 assessed with Flair MRI.
Secondary objectives are to determine whether a single injection of CsA after intravenous
thrombolysis is safe and effective regarding to death and disability.